Production (Stage)
IO Biotech, Inc.
IOBT
$1.55
-$0.05-3.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.42M | -31.33M | -24.02M | -20.69M | -19.46M |
| Total Depreciation and Amortization | 227.00K | 219.00K | 205.00K | 214.00K | 211.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 6.30M | 52.00K | 1.73M | 2.03M |
| Change in Net Operating Assets | -2.55M | 5.19M | 2.95M | 1.76M | -7.72M |
| Cash from Operations | -23.07M | -19.63M | -20.81M | -16.98M | -24.93M |
| Capital Expenditure | -28.00K | -11.00K | -10.00K | -12.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.00K | -11.00K | -10.00K | -12.00K | -11.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 154.00K | -518.00K | 256.00K | -241.00K | -268.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.95M | -20.15M | -20.56M | -17.24M | -25.21M |